Los Angeles, California 90048


Purpose:

The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity in patients harboring pituitary mass lesions of all types.


Study summary:

The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity through computerized collection of comprehensive demographic, therapeutic, pathologic and outcome information on patients harboring pituitary mass lesions of all types.


Criteria:

Inclusion Criteria: - patients with confirmed pituitary disease Exclusion Criteria: - patients who do not have confirmed pituitary disease


NCT ID:

NCT00599092


Primary Contact:

Principal Investigator
Shlomo Melmed, MD
Cedars-Sinai Medical Center, Pituitary Center


Backup Contact:

N/A


Location Contact:

Los Angeles, California 90048
United States

Daniel Akers
Phone: 310-423-3395
Email: daniel.akers@cshs.org

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: January 18, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.